Table 3.
Comparison of diagnostic performance of CEC assay and CA125 assay for EM
| Items | Sensitivity | Specificity | PPV | NPV | LR |
|---|---|---|---|---|---|
| EM versus other benign, n (%) | |||||
| CECs | 17/19 (89.5) | 14/16 (87.5) | 17/19 (89.5) | 14/16 (87.5) | 7.2 |
| CA125 | 13/19 (68.4) | 14/16 (87.5) | 13/15 (86.7) | 14/20 (70.0) | 5.5 |
| EM versus healthy control, n (%) | |||||
| CECs | 17/19 (89.5) | 12/15 (80.0) | 17/20 (85.0) | 12/14 (85.7) | 4.5 |
| CA125 | 13/19 (68.4) | 11/15 (73.3) | 13/17 (76.5) | 11/17 (64.7) | 2.6 |
CECs: Circulating endometrial cells; EM: Endometriosis; NPV: Negative predicative value; PPV: Positive predicative value; LR: Likelihood ratio.